Heron Therapeutics, Inc. (HRTX): Price and Financial Metrics


Heron Therapeutics, Inc. (HRTX)

Today's Latest Price: $17.40 USD

0.14 (-0.80%)

Updated Dec 3 12:53pm

Add HRTX to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 389 in Biotech

See all "A" rated Strong Buy stocks

HRTX Stock Summary

  • HRTX's went public 33.29 years ago, making it older than 91.74% of listed US stocks we're tracking.
  • For HRTX, its debt to operating expenses ratio is greater than that reported by just 10.79% of US equities we're observing.
  • HRTX's price/sales ratio is 15.45; that's higher than the P/S ratio of 89.72% of US stocks.
  • If you're looking for stocks that are quantitatively similar to Heron Therapeutics Inc, a group of peers worth examining would be FREQ, BLUE, APTX, RESN, and MYOV.
  • HRTX's SEC filings can be seen here. And to visit Heron Therapeutics Inc's official web site, go to www.herontx.com.

HRTX Stock Price Chart Interactive Chart >

Price chart for HRTX

HRTX Price/Volume Stats

Current price $17.40 52-week high $26.81
Prev. close $17.54 52-week low $9.60
Day low $17.22 Volume 253,348
Day high $17.57 Avg. volume 1,141,643
50-day MA $16.43 Dividend yield N/A
200-day MA $15.96 Market Cap 1.58B

Heron Therapeutics, Inc. (HRTX) Company Bio


Heron Therapeutics is a biotechnology company focused on improving the lives of patients by developing best-in-class medicines that address major unmet medical needs. The company was founded in 1983 and is based in Redwood City, CA.


HRTX Latest News Stream


Event/Time News Detail
Loading, please wait...

HRTX Latest Social Stream


Loading social stream, please wait...

View Full HRTX Social Stream

Latest HRTX News From Around the Web

Below are the latest news stories about Heron Therapeutics Inc that investors may wish to consider to help them evaluate HRTX as an investment opportunity.

Heron Therapeutics' HTX-011 shows positive action in hernia repair surgery

Heron Therapeutics (HRTX) announces results from EPOCH 2 follow-on study evaluating the efficacy and safety of locally administered HTX-011 300 mg bupivacaine / 9 mg meloxicam into the surgical site in combination with a postoperative non-opioid multimodal analgesia regimen of over-the-counter oral acetaminophen and ibuprofen in 63 patients undergoing open inguinal hernia repair...

Seeking Alpha | September 16, 2020

Heron Therapeutics (HRTX) Investor Presentation - Slideshow

The following slide deck was published by Heron Therapeutics, Inc. in conjunction with this event....

SA Transcripts on Seeking Alpha | September 8, 2020

Heron Therapeutics' (NASDAQ:HRTX) Stock Price Has Reduced48% In The Past Five Years

While not a mind-blowing move, it is good to see that the Heron Therapeutics, Inc. (NASDAQ:HRTX) share price has...

Yahoo | July 24, 2020

Heron Therapeutics Announces Initiation of Phase 2 Clinical Study of CINVANTI® for the Treatment of COVID-19

Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs, today announced the initiation of the GUARDS-1 Study, a Phase 2 clinical study evaluating CINVANTI (aprepitant) injectable emulsion in early hospitalized patients with Coronavirus Disease 2019 (COVID-19). The study initiation follows clearance from the U.S. Food and Drug Administration (FDA) of Heron's Investigational New Drug application for CINVANTI for the treatment of COVID-19.

Yahoo | July 16, 2020

Heron Therapeutics (HRTX) in Focus: Stock Moves 9% Higher

Heron Therapeutics (HRTX) saw a big move last session, as its shares jumped 9% on the day, amid huge volumes.

Yahoo | July 3, 2020

Read More 'HRTX' Stories Here

HRTX Price Returns

1-mo 7.01%
3-mo 26.73%
6-mo -9.80%
1-year -34.22%
3-year 1.46%
5-year -38.41%
YTD -25.96%
2019 -9.41%
2018 43.31%
2017 38.17%
2016 -50.94%
2015 165.41%

Continue Researching HRTX

Here are a few links from around the web to help you further your research on Heron Therapeutics Inc's stock as an investment opportunity:

Heron Therapeutics Inc (HRTX) Stock Price | Nasdaq
Heron Therapeutics Inc (HRTX) Stock Quote, History and News - Yahoo Finance
Heron Therapeutics Inc (HRTX) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.838 seconds.